NexturnBioscience Co. Ltd (089140) — Free Cash Flow Generation Index
NexturnBioscience Co. Ltd (089140) has a Free Cash Flow Generation Index of 0.94x as of September 2025. Free cash flow of ₩4.23 Billion represents 1% of operating cash flow (₩4.51 Billion). Read 089140 current and long-term liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
NexturnBioscience Co. Ltd Free Cash Flow Generation Index (2007–2021)
Historical FCF Generation Index trend for NexturnBioscience Co. Ltd across 12 annual periods. Explore 089140 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for NexturnBioscience Co. Ltd (2007–2021)
Year-by-year Free Cash Flow Generation Index for NexturnBioscience Co. Ltd. For the full company profile including market capitalisation, see market value of NexturnBioscience Co. Ltd.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.87x | ₩3.18 Billion | ₩3.66 Billion | ₩467.60 Million | ▲ +14.4% |
| 2020 | 0.76x | ₩178.75 Million | ₩235.94 Million | ₩1.21 Billion | ▼ -90.2% |
| 2019 | 7.72x | ₩21.12 Billion | ₩2.74 Billion | ₩18.38 Billion | ▲ +656.5% |
| 2018 | 1.02x | ₩9.83 Billion | ₩9.63 Billion | ₩199.42 Million | ▼ -12.9% |
| 2017 | 1.17x | ₩5.95 Billion | ₩5.08 Billion | ₩870.45 Million | ▲ +11.5% |
| 2016 | 1.05x | ₩18.77 Billion | ₩17.88 Billion | ₩893.46 Million | ▼ -28.7% |
| 2015 | 1.47x | ₩2.82 Billion | ₩1.92 Billion | ₩906.54 Million | ▲ +47.1% |
| 2014 | 1.00x | ₩6.49 Billion | ₩6.48 Billion | ₩8.97 Million | ▼ -83.7% |
| 2010 | 6.15x | ₩1.45 Billion | ₩235.94 Million | ₩1.21 Billion | ▲ +475.7% |
| 2009 | 1.07x | ₩1.07 Billion | ₩998.03 Million | ₩68.11 Million | ▼ -11.6% |
| 2008 | 1.21x | ₩1.14 Billion | ₩945.34 Million | ₩197.16 Million | ▼ -56.1% |
| 2007 | 2.75x | ₩6.23 Billion | ₩2.26 Billion | ₩3.97 Billion | — |